^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    milciclib (TZLS-201)

    i
    Associations
    News

    Trials

    Company:
    Nerviano Medical Sciences, Tiziana Life Sci
    Drug class:
    TrkA receptor antagonist, pan-CDK inhibitor
    Related drugs:
    Associations
    News

    Trials

    Apply
    Milciclib in Combination With Gemcitabine in Advanced NSCLC (NCT05651269)
    Phase 2
    Tiziana Life Sciences LTD
    Not yet recruiting
    Last update posted :
    12/15/2022
    Initiation :
    03/15/2023
    Primary completion :
    12/01/2024
    Completion :
    06/01/2025
    KRAS
    |
    KRAS mutation • KRAS G12C • KRAS G12D • KRAS G12V • KRAS G13D • KRAS G12A • KRAS G12 • KRAS G12S • KRAS G13
    |
    gemcitabine • milciclib (TZLS-201)